CVRx Inc (CVRX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $17.30M
Last updated: Nov 17, 2026 at 4:19 PM ET
CVRx Inc (CVRX) Statistics
CVRX has a market cap of $17.30M and an enterprise value of $17.21M. It kept -88.28% of revenue as net income over the last 12 months. Its share count is up 4.12% from a year earlier.
Total Valuation
Enterprise value is 0.53% below the market cap, as cash exceeds debt.
| Market Cap | $17.30M |
|---|---|
| Enterprise Value | $17.21M |
| Latest price (Nov 17, 2026) | $0.61 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 1.2x. Its year-end P/S ranged from 0.7x to 16.8x from 2021 to 2025.
| P/S Ratio | 0.3x |
|---|---|
| Forward P/S | 0.3x |
| P/B Ratio | 1.2x |
Price Statistics
The stock is down 93.41% over 52 weeks and trades 65.34% below its 50-day average.
| Beta (1Y) | 0.70 |
|---|---|
| 52-Week Change | -93.41% |
| 1-Month Change | -54.74% |
| 3-Month Change | -78.33% |
| 6-Month Change | -89.83% |
| 5-Year Change | -91.66% |
| Total Return (1Y) | -93.41% |
| Total Return (3Y CAGR) | -67.43% |
| Total Return (5Y CAGR) | -46.82% |
| Max Drawdown (1Y) | -93.92% |
| Max Drawdown (3Y) | -98.16% |
| Sharpe Ratio (1Y) | -1.95 |
| Correlation with SPY (1Y) | 0.07 |
| 50-Day Average | $1.76 |
| 200-Day Average | $4.94 |
| 52-Week Range | $0.57 to $10.28 |
| RSI (14 Days) | 21.2 |
| Average Volume (20 Days) | 843.76K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 6.80x current liabilities, and total debt is 4.24x shareholder equity.
| Current Ratio | 6.80x |
|---|---|
| Quick Ratio | 5.71x |
| Debt / Equity | 4.24x |
| Interest Coverage | -7.66x |
Returns and Efficiency
Return on invested capital is -65.00% over the last 12 months, against a 5-year average of -53.45%.
| Return on Equity (ROE) | -385.45% |
|---|---|
| Return on Assets (ROA) | -60.79% |
| Return on Invested Capital (ROIC) | -65.00% |
| Return on Capital Employed (ROCE) | -62.73% |
| ROE (5Y Average) | -68.33% |
| ROA (5Y Average) | -38.59% |
| ROIC (5Y Average) | -53.45% |
| Asset Turnover | 0.61x |
| Inventory Turnover | 0.59x |
| Receivables Turnover | 6.35x |
| Cash Conversion Cycle | 488 days |
Scores
CVRX has an Altman Z-Score of -10.06, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -10.06 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $60.33M over the last 12 months is up 7.79% from the 12 months before.
| Revenue | $60.33M |
|---|---|
| Revenue Growth (YoY) | +7.79% |
| Gross Profit | $52.43M |
| Operating Income | -$49.41M |
| Pretax Income | -$53.27M |
| Net Income | -$53.26M |
| EBITDA | -$45.98M |
| EBIT | -$47.11M |
| Reported EPS (TTM) | -$2.01 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 15.77% of the $87.61M in total assets.
| Cash and Equivalents | $58.75M |
|---|---|
| Total Debt | $58.66M |
| Net Cash | $91.00K |
| Net Cash Per Share | $0.00 |
| Working Capital | $72.51M |
| Shareholder Equity | $13.82M |
| Book Value Per Share | $0.51 |
| Total Assets | $87.61M |
| Total Liabilities | $73.79M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $400.00K of capital spending, operating cash flow left -$42.05M of free cash flow.
| Operating Cash Flow | -$41.65M |
|---|---|
| Capital Expenditures | $400.00K |
| Free Cash Flow | -$42.05M |
| FCF Per Share | -$1.58 |
| Depreciation and Amortization | $1.13M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -81.90%.
| Gross Margin | 86.90% |
|---|---|
| Operating Margin | -81.90% |
| Pretax Margin | -88.29% |
| Net Margin | -88.28% |
| EBITDA Margin | -76.21% |
| EBIT Margin | -78.09% |
| FCF Margin | -69.69% |
| Gross Margin (5Y Average) | 80.60% |
Growth
Revenue grew 36.11% a year over 3 years.
| Revenue Growth (3Y CAGR) | +36.11% |
|---|---|
| Revenue Growth (5Y CAGR) | +56.40% |
| Book Value Per Share Growth (2Y CAGR) | -35.87% |
| Tangible Book Per Share Growth (2Y CAGR) | -35.87% |
Dividends and Yields
CVRX does not pay a dividend. Its free cash flow yield is -252.56%.
| FCF Yield | -252.56% |
|---|---|
| Buyback Yield | -39.14% |
| Shareholder Yield | -39.14% |
Peer Position
Against 10 similar companies, CVRX has the 10th highest P/S and the 4th highest ROIC.
P/S RatioPeer median 1.6x
ROICPeer median -137.49%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.65%
| P/S Ratio | 0.3x vs 1.6x median |
|---|---|
| ROIC | -65.00% vs -137.49% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +7.79% vs +11.65% median |
Analyst Forecast
Consensus estimates put revenue growth at 1.28% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +1.28% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CVRX
What is CVRX's market cap?
CVRX has a market cap of $17.30M. Its enterprise value, which adds debt and subtracts cash, is $17.21M.
How many shares of CVRX are outstanding?
CVRX has 27.25M shares outstanding. The count is up 4.12% from a year earlier.
Does CVRX pay a dividend?
No. CVRX does not pay a dividend.
How much debt does CVRX have?
CVRX has $58.66M of total debt and $58.75M of cash and equivalents, a net cash position of $91.00K.
CVRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors